Rigel Pharmaceuticals Inc
RIGL
Revenue
36.84M
▲7.31M▲24.74%
3 Months ChangeAssets
128.41M
▲1.89M▲1.49%
3 Months ChangeLiabilities
158.32M
▲132.00k▲0.08344%
3 Months ChangeFree Cash Flow
-25.86M
▼-5.84M▼-29.14%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-19
Form 8-K
ID: 0001104659-24-101327
2024-09-03
Form 8-K
ID: 0001104659-24-096047
2024-08-06
Form 8-K
ID: 0001104659-24-086271
2024-08-06
Form 10-Q
ID: 0001558370-24-011079
2024-06-27
Form 8-K
ID: 0001104659-24-075697
2024-06-25
Form 8-K
ID: 0001104659-24-074574
2024-05-29
Form 8-K
ID: 0001104659-24-066058
2024-05-07
Form 8-K
ID: 0001104659-24-058017
2024-05-07
Form 10-Q
ID: 0001558370-24-007041
2024-04-12
Form 8-K
ID: 0001104659-24-046527